Abstract
Hypertension is an important public health issue because of its association with a number of significant diseases and adverse outcomes. However, there are important ethnic differences in the pathogenesis and cardio-/cerebrovascular consequences of hypertension. Given the large populations and rapidly aging demographic in Asian regions, optimal strategies to diagnose and manage hypertension are of high importance. Ambulatory blood pressure monitoring (ABPM) is an important out-of-office blood pressure (BP) measurement tool that should play a central role in hypertension detection and management. The use of ABPM is particularly important in Asia due to the specific features of hypertension in Asian patients, including a high prevalence of masked hypertension, disrupted BP variability with marked morning BP surge, and nocturnal hypertension. This HOPE Asia Network document summarizes region-specific literature on the relationship between ABPM parameters and cardiovascular risk and target organ damage, providing a rationale for consensus-based recommendations on the use of ABPM in Asia. The aim of these recommendations is to guide and improve clinical practice to facilitate optimal BP monitoring with the goal of optimizing patient management and expediting the efficient allocation of treatment and health care resources. This should contribute to the HOPE Asia Network mission of improving the management of hypertension and organ protection toward achieving “zero” cardiovascular events in Asia.
Original language | English |
---|---|
Pages (from-to) | 1250-1283 |
Number of pages | 34 |
Journal | Journal of Clinical Hypertension |
Volume | 21 |
Issue number | 9 |
DOIs | |
Publication status | Published - 2019 Sept 1 |
Bibliographical note
Funding Information:Funding information Editorial and writing support was provided by Nicola Ryan, independent medical writer, funded by Pfizer. The meeting during which these recommendations were formulated and discussed was made possible by an unrestricted educational grant from Pfizer and was supported by A&D. However, the recommendations were developed by the HOPE Asia Network independently of Pfizer and A&D.
Funding Information:
Editorial and writing support was provided by Nicola Ryan, independent medical writer, funded by Pfizer. The meeting during which these recommendations were formulated and discussed was made possible by an unrestricted educational grant from Pfizer and was supported by A&D. However, the recommendations were developed by the HOPE Asia Network independently of Pfizer and A&D.
Publisher Copyright:
©2019 Wiley Periodicals, Inc.
All Science Journal Classification (ASJC) codes
- Internal Medicine
- Endocrinology, Diabetes and Metabolism
- Cardiology and Cardiovascular Medicine